Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Sales | 645,200 | 640,700 | 622,700 | 626,900 | 627,384 |
| Cost of Goods | 376,100 | 386,700 | 359,900 | 380,100 | 373,222 |
| Gross Profit | 269,100 | 254,000 | 262,800 | 246,800 | 254,162 |
| Operating Expenses | 179,000 | 167,700 | 164,700 | 164,900 | 188,454 |
| Operating Income | 90,200 | 87,000 | 99,000 | 82,000 | 65,930 |
| Interest Expense | 7,500 | 7,000 | 6,900 | 6,800 | 9,024 |
| Other Income | 3,900 | 14,100 | 3,700 | 6,600 | 2,828 |
| Pre-tax Income | 86,600 | 94,100 | 95,800 | 81,800 | 59,734 |
| Income Tax | 30,200 | 23,000 | 35,500 | 31,200 | 21,361 |
| Net Income Continuous | 56,400 | 71,100 | 60,300 | 50,600 | 38,373 |
| Net Income | $56,400 | $71,100 | $60,300 | $50,600 | $38,373 |
| EPS Basic Total Ops | 0.55 | 0.69 | 0.59 | 0.49 | 0.37 |
| EPS Basic Continuous Ops | 0.55 | 0.69 | 0.59 | 0.49 | 0.37 |
| EPS Diluted Total Ops | 0.49 | 0.62 | 0.53 | 0.45 | 0.34 |
| EPS Diluted Continuous Ops | 0.48 | 0.60 | 0.51 | 0.43 | 0.33 |
| EBITDA(a) | $132,900 | $130,500 | $141,500 | $124,000 | $130,345 |